Alteplase - Boehringer Ingelheim
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Genentech; Kyowa Kirin; Mitsubishi Tanabe Pharma Corporation; Roche
- Drug Class Anti-ischaemics; Antihaemorrhagics; Antithrombotics; Cardiovascular therapies; Plasminogen activator enzymes; Recombinant proteins; Thrombolytics; Vascular disorder therapies
- Mechanism of Action Fibrinolytic agents; Plasminogen activator stimulants; Plasminogen activators
- USA Patent Applicants GENENTECH
- USA Patents 132
- BLAs 1
- International Patents 1,564
Disclaimer